Clinical Trial Update: Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial [Phase 3]

View source ↗

Summary

A Phase 3 study named EQUATE is testing a combination therapy for adults with newly diagnosed multiple myeloma, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Combination Therapy

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma | Phase 3 | Status: RECRUITING